Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow SWK Holdings Corp

Get SEC filing alerts via email and in your feed for SWK Holdings Corp

SWKH SWKHL

SWK Holdings Corp

About SWK Holdings Corp

SWK Holdings Corporation is a specialty finance and pharmaceutical development company. It provides customized healthcare financing solutions, including royalty and debt investments in life sciences, and offers pharmaceutical formulation, development, and manufacturing services. Serving biotech, medical device, and pharma markets, it leverages intellectual property and strategic partnerships to generate income through interest, royalties, and licensing, focusing on innovative healthcare products and technologies.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from SWK Holdings Corp

1
1
SWK Holdings Corp SWK Holdings Reports $2.5 Million Net Loss for Fiscal Year 2025, Sells Pharmaceutical Development Assets

Via official filing (AI summary) | 3 months ago | 0 comments

2
1
SWK Holdings Corp SWK Holdings Reports Q3 2025 Net Income of $8.8 Million, Revenue Growth

Via official filing (AI summary) | 7 months ago | 0 comments

3
1
SWK Holdings Corp SWK Holdings Reports Decrease in Revenue and Net Income for Quarter Ended June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
SWK Holdings Corp SWK Holdings Reports $4.5 Million Net Income in Q1 2025, Up from $468,000 in Q1 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

5
1
SWK Holdings Corp SWK Holdings Reports Revenue Increase to $45 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
SWK Holdings Corp SWK Holdings Reports Q3 Revenue Growth, Net Income Decline Amid Increased Credit Losses and Interest Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments